ACTRN12620000349943终止未知
A Prospective, Non-Randomized Single-Arm Pilot Study to Assess the Safety and Effectiveness of Instylla Hydrogel Embolic System (HES) For Transcatheter Embolization of Vascular Bleeds
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- Instylla Inc
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Male or female patients age greater than or equal to 18 years old
- •2. Transcatheter vascular embolization of vascular bleeds is clinically indicated
- •3. Positive angiographic findings of bleeding
排除标准
- •1. Ongoing adverse effect that may confound the evaluation of the Instylla HES
- •2. Pregnant females
- •3. The patient has other concurrent conditions or known history that in the opinion of the Investigator would be unlikely to receive clinical benefit from the study procedure or participation in the study may compromise patient safety or study objectives (including but not limited to ongoing infection, morbid obesity).
研究者
相似试验
招募中
Unknown
Evaluation of the NaviFUS System in drug resistant epilepsyDrug Resistant Temporal Lobe EpilepsyNeurological - EpilepsyTemporal Lobe EpilepsyACTRN12623000382673Genovate-NaviFUS (Australia) Pty Ltd18
进行中（未招募）
1 期
A single-center study to assess the effect of lamivudine (3TC) on cognitive impairment (alterations in thinking, learning, memory...) by the analysis of the plasma of patients with Mild Cognitive Impairment (MCI)Mild Cognitive impairment due to Alzheimer DiseaseMedDRA version: 27.0Level: LLTClassification code: 10090501Term: Mild cognitive impairment Class: 100000004852MedDRA version: 21.1Level: LLTClassification code: 10009846Term: Cognitive impairment Class: 10029205MedDRA version: 20.0Level: LLTClassification code: 10001896Term: Alzheimer's disease Class: 10029205CTIS2024-514330-20-00Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia25
进行中（未招募）
1 期
Eine offene, nicht randomisierte, einarmige Pilotstudie zur Beurteilung der Wirksamkeit von Erythropoetin bei Friedreich Ataxie.Die Friedreich Ataxie (FRDA) ist eine autosomal-rezessiv vererbte, progressive neurodegenerative Erkrankung, die mit einer Inzidenz von rund 1:50.000 auftritt. Es handelt sich dabei um die am häufigsten vorkommende Ataxie beim Menschen. Sie manifestiert sich klinisch initial als spinozerebelläre Ataxie, im weiteren Krankheitsverlauf tritt meist eine hypertrophe Kardiomyopathie hinzu, deren Komplikationen häufig für den frühen Tod der Patienten verantwortlich sind.EUCTR2005-005938-12-ATDr. Sylvia Boesch12
招募中
不适用
A study of providing adult smokers, who smoke at least one cigarette per day, the opportunity to sample a range of nicotine replacement therapies (NRTs) in everyday non-medical community locations, to determine if this is acceptable to smokers, and whether it increases their motivation to quit smoking, encourages them to use NRTs, and helps them to quit smoking and remain abstinent for three months.ACTRN12614000054617Ministry of Health1,000
已完成
1 期
A prospective, single arm, single centre pilot trial to establish the safety and efficacy of the Oventus device to treat mild to moderate obstructive sleep apnoea and snoring.Mild to moderate obstructive sleep apnoeaSnoringRespiratory - Sleep apnoeaACTRN12615000028505Oventus Pty Ltd30